English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Hydroxyapatite [Ca10(PO4)6(OH)2, HA] is commonly used as bioactive materials in bone graft, orthopaedic application, dental implant etc. since its unique ability to bond to bone after implantation (Ellinge et al. 1986). The ability of bond to bone can be predicted by its capacity to form HA layer on the surface upon immersed in simulated body fluid (SBF) solution, of which the ion concentrations is similar to human plasma (Nery et al. 1990). SBF screening is commonly used to predict the ability to bond to bone since its simplicity and economic, before implant into a live animal. In the other hand, the β-tricalcium phosphate [β-Ca3(PO4)2, β-TCP] is known as biodegradable materials, but exposes its weak bioactivity (Petrov et al. 2001). So if we can combine HA and β-TCP with proper ration, we are also possible to control the advantage of biphasic calcium phosphate (BCP): high bioactivity and its fast biodegradation (Victoria & Gnanam 2002; Aslanidou et al. 2012).

Synthesis of Biphasic Calcium Phosphate and its Behaviour in Simulated Body Fluid